Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThis change is a minor revision update from v3.2.0 to v3.3.2 and does not modify study content, eligibility criteria, endpoints, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedRemoved the government funding status notice about potential data updates and delays on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check37 days agoChange DetectedNo substantive changes to core study information (eligibility, interventions, outcomes, or enrollment) are visible in the new screenshot; any differences appear cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference2%

- Check66 days agoChange DetectedUpdated page to version v3.1.0 and removed several topic categories (Electromagnetic Radiation, Magnetic Phenomena, Electromagnetic Phenomena), indicating a scope reduction and a new version label.SummaryDifference0.2%

- Check80 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.